Impact of epidermal growth factor receptor T790M testing in relapsed non-small cell lung cancer: A narrative review of the T790M reflex testing algorithm-Reference-Cited by-同舟云学术

Impact of epidermal growth factor receptor T790M testing in relapsed non-small cell lung cancer: A narrative review of the T790M reflex testing algorithm

Published:2021 Issue:4 Volume:4 Page:692
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:Cancer Res Stat Treat

Author:

Prabhash Kumar,Batra Ullas

Publisher

Medknow

Subject

General Medicine

Reference68 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Lung cancer in India: Challenges and perspectives;Behera;J Thorac Oncol,2017

3. The Global Cancer Observatory 2020: India Factsheets, Lung Cancer. Available from: https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf. [Last accessed on 2021 Sep 06].

4. Biomarkers in non-small cell lung cancers: Indian consensus guidelines for molecular testing;Prabhash;Adv Ther,2019

5. Lung cancer in the Indian subcontinent;Noronha;South Asian J Cancer,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India;South Asian Journal of Cancer;2024-08-23

2. Gefitinib triumphs: Long-term advantages over chemotherapy in the treatment of EGFR mutant lung cancer;Cancer Research, Statistics, and Treatment;2024-01

3. Phase III randomized controlled trial of gefitinib versus chemotherapy in EGFR-positive treatment-naïve metastatic lung cancer: Long-term outcome after eight years;Cancer Research, Statistics, and Treatment;2024-01

4. Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: Real world data;2023-12-20